William J. Chase, EVP, Chief Financial Officer at AbbVie Inc. (ABBV), sold 8,495 shares at $68.00 ($578K) on 2014-12-22, disclosed to the SEC on 2014-12-22.
Scheduled sale ($578k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABBV | SELL | 2018-12-14 | $5.4M | — | Filing → |
| ABBV | SELL | 2018-03-02 | $12.9M | — | Filing → |
| ABBV | SELL | 2017-05-19 | $2.5M | — | Filing → |